BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 2130364)

  • 1. Ultrasonography and water content of the liver in chronic diffuse liver disease.
    Szebeni A; Pintér E; Stotz G; Tolvaj G; Juhász M; Dávid K
    Acta Med Hung; 1990; 47(3-4):163-70. PubMed ID: 2130364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of structural change in diffuse liver disease with frequency domain analysis of ultrasound.
    Suzuki K; Hayashi N; Sasaki Y; Kono M; Kasahara A; Imai Y; Fusamoto H; Kamada T
    Hepatology; 1993 Jun; 17(6):1041-6. PubMed ID: 8514252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of ultrasound attenuation and histopathological parameters of the liver in chronic diffuse liver diseases.
    Szebeni A; Tolvaj G; Zalatnai A
    Eur J Gastroenterol Hepatol; 2006 Jan; 18(1):37-42. PubMed ID: 16357617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Accuracy of sonography in the diagnosis of diffuse liver parenchymal diseases--comparison of sonography and liver histology].
    Steinmaurer HJ; Jirak P; Walchshofer J; Clodi PH
    Ultraschall Med; 1984 Jun; 5(3):98-103. PubMed ID: 6474150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility study of ultrasonic fatty liver biopsy: texture vs. attenuation and backscatter.
    Gaitini D; Baruch Y; Ghersin E; Veitsman E; Kerner H; Shalem B; Yaniv G; Sarfaty C; Azhari H
    Ultrasound Med Biol; 2004 Oct; 30(10):1321-7. PubMed ID: 15582231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of liver histology with ultrasonography in assessing diffuse parenchymal liver disease.
    Joseph AE; Saverymuttu SH; al-Sam S; Cook MG; Maxwell JD
    Clin Radiol; 1991 Jan; 43(1):26-31. PubMed ID: 1999069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ultrasound in the diagnostics of fatty liver in obesity].
    Szebeni A; Tolvaj G; Stotz G
    Orv Hetil; 2010 Apr; 151(14):572-5. PubMed ID: 20332074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic venography and wedge hepatic vein pressure measurements in diffuse liver disease.
    Cavaluzzi JA; Sheff R; Harrington DP; Kaufman SL; Barth K; Maddrey WC; White RI
    AJR Am J Roentgenol; 1977 Sep; 129(3):441-6. PubMed ID: 409197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dependence of ultrasonic attenuation of liver on pathologic fat and fibrosis: examination with experimental fatty liver and liver fibrosis models.
    Suzuki K; Hayashi N; Sasaki Y; Kono M; Kasahara A; Fusamoto H; Imai Y; Kamada T
    Ultrasound Med Biol; 1992; 18(8):657-66. PubMed ID: 1440987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative studies of laparoscopy, histology and gray-scale echotomography in diffuse diseases of the liver.
    Vogel HM; Scherer K; Look D
    Endoscopy; 1980 Jul; 12(4):166-74. PubMed ID: 6447063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hepatocyte pathology in viral and toxic injuries to the liver].
    Kartashova OIa; Terent'eva LA; Zaltsmane VK; Maksimova LA
    Vestn Akad Med Nauk SSSR; 1983; (11):74-81. PubMed ID: 6362270
    [No Abstract]   [Full Text] [Related]  

  • 12. [Echomorphological comparisons in chronic diseases of the liver].
    Iakhontova OI; Dudanova OP; Gur'ianova SD; Popova TV
    Ter Arkh; 1989; 61(2):52-5. PubMed ID: 2658194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis of diffuse hepatocellular diseases using SPECT.
    Kodama T; Watanabe K; Hoshi H; Jinnouchi S; Arakawa K; Kusumoto S; Honda H
    J Nucl Med; 1986 May; 27(5):616-9. PubMed ID: 3486958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simple computer quantitation of spleen-to-liver ratios in the diagnosis of hepatocellular disease.
    Wasnich R; Glober G; Hayashi T; Vicher T; Yeh F
    J Nucl Med; 1979 Feb; 20(2):149-54. PubMed ID: 372503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The role of ultrasonography in the diagnosis of diffuse liver disease].
    Berrut C; Curati W; de Gautard R; Widmann JJ; Godin N; Loizeau E
    Schweiz Med Wochenschr; 1986 Feb; 116(7):215-8. PubMed ID: 3513304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sonographic diagnosis of diffuse liver disease.
    Zwiebel WJ
    Semin Ultrasound CT MR; 1995 Feb; 16(1):8-15. PubMed ID: 7718284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Scintigraphic aspects of hepatic steatosis. Histologic and endoscopic correlations].
    Banciu T; Berinde L; Prodan P; Deutsch G; Tudose N; Berinde L
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1979; 31(1):57-64. PubMed ID: 37571
    [No Abstract]   [Full Text] [Related]  

  • 18. Xenon-133 retention in hepatic steatosis-correlation with liver biopsy in 45 patients: concise communication.
    Ahmad M; Perrillo RP; Sunwoo YC; Donati RM
    J Nucl Med; 1979 May; 20(5):397-401. PubMed ID: 541696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The correlation of the isotopic liver/spleen ratio with the tissue damage in chronic diffuse hepatopathies].
    Bataller Sifre R; Roselló Morera JF; Bataller Alberola R; Ferrández Izquierdo A; Castillo Pallarés J; Bort Martí J; Galindo Puerto MJ
    Rev Esp Enferm Dig; 1994 Sep; 86(3):651-4. PubMed ID: 7986597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sonographic measurement of the thickness of subcutaneous tissues in nonalcoholic fatty liver disease versus other chronic liver diseases.
    Riley TR; Bruno MA
    J Clin Ultrasound; 2005 Dec; 33(9):439-41. PubMed ID: 16281268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.